{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:kbc-pharmaceutical-company",
    "identifier": "hg:company:kbc-pharmaceutical-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:16+00:00",
    "name": "KBC Pharmaceutical Company",
    "slug": "kbc-pharmaceutical-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/kbc-pharmaceutical-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/kbc-pharmaceutical-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/kbc-pharmaceutical-company",
    "summary": "",
    "machine_summary": "KBC Pharmaceutical Company KBC Pharmaceutical Company is best understood as a healthcare supply and pharmaceutical import-distribution company rather than a standard medicine manufacturer. Its relevance comes from connecting foreign pharmaceutical products, specialized therapies, public and private healthcare demand, import licensing, regulated distribution, and payment constraints. For Hormuz Group, KBC is useful for understanding where Iran’s healthcare system still depends on imported medicines, specialized products, and compliant procurement channels. In the Hormuz investment graph, KBC connects healthcare demand, pharmaceutical imports, specialized medicine supply, distributor networks, regulatory approvals, and money-transfer friction. It is useful for screening import-dependent healthcare segments, supply-shortage risk, distributor quality, counterparty exposure, and market-entry constraints for foreign pharmaceutical or medical-product companies. Commercial use should verify current licenses, product portfolio, principals or suppliers, payment channels, sanctions exposure, regulatory approvals, and real distribution capacity before reliance. KBC Company is focused on pharmaceutical import, distribution, procurement, sale, and supply of specialized medicines and healthcare products, with particular relevance to vaccines, oncology-related products, blood derivatives, and imported medical or pharmaceutical goods. Its role is linked to regulated imports, healthcare procurement, supply continuity, and money-transfer constraints. province: Tehran industry: Healthcare & Pharma, Medical Devices, Pharmaceuticals market: Consumer Demand, Healthcare, Imports, Supply Chains challenges: Compliance, Import Dependence, Money Transfer, Supply Shortage company_type: Distributor, Importer, Public Company city: Tehran",
    "published_at": "2026-06-28T18:12:53+00:00",
    "modified_at": "2026-06-28T18:12:53+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 3,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/provinces/tehran/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 122,
                "name": "Medical Devices",
                "slug": "medical-devices",
                "url": "https://hormuz.group/industry/healthcare-pharma/medical-devices/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 57,
                "name": "Imports",
                "slug": "imports",
                "url": "https://hormuz.group/market/trade-transit/imports/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 176,
                "name": "Import Dependence",
                "slug": "import-dependence",
                "url": "https://hormuz.group/challenges/market-gaps/import-dependence/"
            },
            {
                "id": 160,
                "name": "Money Transfer",
                "slug": "money-transfer",
                "url": "https://hormuz.group/challenges/financial-barriers/money-transfer/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            }
        ],
        "company_type": [
            {
                "id": 302,
                "name": "Distributor",
                "slug": "distributor",
                "url": "https://hormuz.group/company-type/distributor/"
            },
            {
                "id": 301,
                "name": "Importer",
                "slug": "importer",
                "url": "https://hormuz.group/company-type/importer/"
            },
            {
                "id": 306,
                "name": "Public Company",
                "slug": "public-company",
                "url": "https://hormuz.group/company-type/public-company/"
            }
        ],
        "city": [
            {
                "id": 384,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/cities/tehran/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Tehran",
        "industry": "Healthcare & Pharma, Medical Devices, Pharmaceuticals",
        "market": "Consumer Demand, Healthcare, Imports, Supply Chains",
        "challenges": "Compliance, Import Dependence, Money Transfer, Supply Shortage",
        "company_type": "Distributor, Importer, Public Company",
        "city": "Tehran"
    },
    "fields_summary": {
        "legal_name": "KBC Company",
        "website": "https://kbcco.com",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "کی بی سی",
        "listing_status": "listed_ifb",
        "products_services": "KBC Company is focused on pharmaceutical import, distribution, procurement, sale, and supply of specialized medicines and healthcare products, with particular relevance to vaccines, oncology-related products, blood derivatives, and imported medical or pharmaceutical goods. Its role is linked to regulated imports, healthcare procurement, supply continuity, and money-transfer constraints.",
        "export_relevance": "none",
        "short_profile": "KBC Pharmaceutical Company is best understood as a healthcare supply and pharmaceutical import-distribution company rather than a standard medicine manufacturer. Its relevance comes from connecting foreign pharmaceutical products, specialized therapies, public and private healthcare demand, import licensing, regulated distribution, and payment constraints. For Hormuz Group, KBC is useful for understanding where Iran’s healthcare system still depends on imported medicines, specialized products, and compliant procurement channels.",
        "investment_relevance": "In the Hormuz investment graph, KBC connects healthcare demand, pharmaceutical imports, specialized medicine supply, distributor networks, regulatory approvals, and money-transfer friction. It is useful for screening import-dependent healthcare segments, supply-shortage risk, distributor quality, counterparty exposure, and market-entry constraints for foreign pharmaceutical or medical-product companies. Commercial use should verify current licenses, product portfolio, principals or suppliers, payment channels, sanctions exposure, regulatory approvals, and real distribution capacity before reliance."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "KBC Company",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "کی بی سی",
        "export_relevance": "none",
        "verification_status": "basic",
        "data_confidence": "high",
        "listing_status": "listed_ifb",
        "last_updated": "28/06/2026",
        "website": "https://kbcco.com",
        "products_services": "KBC Company is focused on pharmaceutical import, distribution, procurement, sale, and supply of specialized medicines and healthcare products, with particular relevance to vaccines, oncology-related products, blood derivatives, and imported medical or pharmaceutical goods. Its role is linked to regulated imports, healthcare procurement, supply continuity, and money-transfer constraints.",
        "short_profile": "KBC Pharmaceutical Company is best understood as a healthcare supply and pharmaceutical import-distribution company rather than a standard medicine manufacturer. Its relevance comes from connecting foreign pharmaceutical products, specialized therapies, public and private healthcare demand, import licensing, regulated distribution, and payment constraints. For Hormuz Group, KBC is useful for understanding where Iran’s healthcare system still depends on imported medicines, specialized products, and compliant procurement channels.",
        "investment_relevance": "In the Hormuz investment graph, KBC connects healthcare demand, pharmaceutical imports, specialized medicine supply, distributor networks, regulatory approvals, and money-transfer friction. It is useful for screening import-dependent healthcare segments, supply-shortage risk, distributor quality, counterparty exposure, and market-entry constraints for foreign pharmaceutical or medical-product companies. Commercial use should verify current licenses, product portfolio, principals or suppliers, payment channels, sanctions exposure, regulatory approvals, and real distribution capacity before reliance.",
        "source_note": "Based on public company, market, sector, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 11
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "ticker_symbol": {
            "type": "string",
            "present": true,
            "length": 14
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 17
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 389
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 536
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 605
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 175
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, market, sector, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "28/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "28/06/2026"
    }
}